Opinion
Pfizer COVID-19 vaccine could be available for children under 5 as soon as next month: report
Pfizer and BioNTech plan to submit a request for emergency use authorization for his or her COVID-19 vaccine in youngsters six months to five years previous as quickly as Tuesday, which may set the vaccine as much as be permitted for younger youngsters within the coming weeks, the Washington Publish reviews.
The businesses started a medical trial final yr to look at the results of two doses of 3-microgram pictures in youngsters youthful than 5.
The vaccine is already permitted for emergency use in youngsters between the ages of 5 and 11, who obtain 10 microgram doses. Kids older than 12 and adults obtain 30 microgram doses.
‘STEALTH’ OMICRON VARIANT BA.2 CIRCULATING IN ALMOST HALF OF US, BUT CDC EXERCISES CAUTION: REPORT
Two 3-microgram doses had been discovered to be efficient in youngsters between six months and a pair of years previous, however youngsters between the ages of two and 5 didn’t have the identical immune response because the bigger two-dose sequence in older youngsters.
That discovering prompted Pfizer to check the administration of a 3rd 3-microgram dose two months after the final dose.
The FDA urged Pfizer and BioNTech to go forward and submit the two-dose information so the approval course of may start, in keeping with the Washington Publish.
Pfizer’s vaccine was approved for kids between the ages of 5 and 11 in late October.
About three months later, solely 8.7 million youngsters between the ages of 5 and 11 have obtained no less than one dose and 6.2 million are totally vaccinated.
CLICK HERE TO GET THE FOX NEWS
There have been 11.4 million COVID-19 circumstances in youngsters because the pandemic started, making up about 18.6% of all circumstances, however youngsters solely signify 1.6%-4.4% of all COVID-19 hospitalizations and 0.00%-0.25% of all COVID-19 deaths, in keeping with the American Academy of Pediatrics.
Supply: Fox Information